FDB is introducing FDB Navigo, a cloud-based solution that provides retail pharmacists with targeted, consolidated and actionable clinical guidance at the most optimal time in their workflow.
Developed over the past three years in collaboration with a major retail pharmacy chain, FDB Navigo streamlines the retail pharmacist’s workflow by changing the focus of medication safety alerts and the way these alerts are presented and processed. Specifically, FDB Navigo provides actionable guidance to the pharmacist based on the most important risks to the patient as reflected in the patient's clinical record in the pharmacy’s system.
Additionally, FDB Navigo consolidates the appropriate information across all major clinical domains, including drug interactions, allergies, precautions and dosing information, to eliminate the current “siloed” approach in which retail pharmacists need to consider alerts within each clinical domain.
FDB Navigo assists the retail pharmacist to determine the next best step for each patient, whether that is to fill the prescription, provide additional guidance to the patient or follow up with the patient’s physician.
“As retail pharmacists take on greater responsibilities beyond filling prescriptions and providing general advice for taking medications, demands on their time and energy have increased,” said president Bob Katter. “FDB is pleased to offer a transformative clinical guidance solution that helps pharmacists meet these demands and practice at the top of their license in order to best serve the health and safety needs of their patients.”
In addition, the tool also identifies therapeutic alternatives when available based on the patient’s risk and equips the pharmacist with a scripted narrative that can be used when counseling the patient or when discussing interventions with the physician.
Moreover, FDB Navigo helps to significantly reduce the number of alerts retail pharmacists receive in order to alleviate their cognitive burden, according to the company. Unlike legacy clinical screening solutions, this new solution helps retail pharmacists, who are increasingly taking on expanded roles in patient care, to easily identify and respond to medication risks pertinent to individual patients to improve patient safety. Ultimately, FDB Navigo gives retail pharmacists more time and cognitive space to consult with patients and offer more primary care services, according to the company.
“FDB Navigo leverages additional patient information, such as prescription history, previous alert outcomes and universal medication schedule, to provide patient-specific context for clinical guidance, helping to ensure medication safety,” said Chirag Patel, senior product manager. “This product development approach, also reflected in other solutions within FDB’s PatientFirst suite, helps retail pharmacists make more precise, evidence-based decisions.”